Progressive systemic sclerosis (PSS) is a multisystem disorder. The prevalence of different forms of systemic involvement as determined by Campbell and LeRoy (1975) is shown in the Table. As it may be difficult to detect early and mild organ involvement the true prevalence of several of the manifestations is probably under estimated. Such changes are due to a combination of widespread vascular disease, fibrosis, and atrophy. (Fleischmajer, 1964) failed to show excess collagen in the skin. Moreover, x-ray diffraction and amino-acid analysis (Fleischmajer, 1964; Neldner et al., 1966) and of the growing edge of a plaque of morphoea showed more new collagen at the edge than at the centre. Another index of the rate of collagen synthesis is obtained by determining the activity of the enzyme protocollagen proline hydroxylase. Raised levels have been found in scleroderma skin (Uitto et al., 1969) . Indeed, Keiser et al. (1971) found raised levels in clinically unaffected skin of PSS patients although the levels were higher still where the disease was clinically manifest.
Rates of collagen synthesis have been measured more directly by culturing scleroderma tissue in a medium containing radioactive-labelled proline and measuring the rate of synthesis of hydroxyproline, an amino-acid unique to collagen. Keiser and Sjoerdsma (1969) reported raised synthesis rates in tissue culture of human skin, but this was not confirmed by Uitto et al. (1970a) . This discrepancy may reflect one of the major problems of tissue culture studies-that minor variations in technique or in the media may profoundly alter the results. However, LeRoy (1972 LeRoy ( , 1974 and Fleischmann and LeRoy (1975) cultured PSS skin fibroblasts and demonstrated increased synthesis of soluble collagen compared with control fibroblasts. This ability to synthesize excess collagen persisted for up to 15 subcultures of the original primary culture. The collagens formed by normal and PSS fibroblasts were identical, suggesting that the disease is due to altered regulation of the fibroblasts but with normal assembly of the collagen molecule. However, Kovacs and Fleischmajer (1974) There is no consistent change in immunoglobulin levels in PSS (Spencer and Winkelmann, 1971) . Antinuclear factor has been reported in up to 90% of patients with systemic sclerosis and rheumatoid factor in up to 35% (Rothfield and Rodnan, 1968; Clark et al., 1971; Jordan et al., 1971; Rodnan, 1972; Davis and Jayson, 1976) . The antinuclear factor is usually of low titre and no correlation has been found between the extent or severity of the disease and the antinuclear activity (Rothfield and Rodnan, 1968 (Campbell and LeRoy, 1975) . In PSS it is always bilateral in contrast with occasionally being unilateral when local factors play some part in its pathogenesis (Velayos et al., 1971) . This hyperreactivity has been documented by peripheral blood flow measurements (LeRoy et al., 1971; Coffman and Cohen, 1971) . The specific defects seem to be in capillary blood flow with selective vasoconstriction of the blood vessels that regulate heat exchange. Such vascular hyperreactivity is not restricted to skin. Cannon et al. (1974) demonstrated reduction of renal blood flow in PSS patients on induction of cutaneous Raynaud's phenomenon by cooling, in contrast with the normal slight increase in renal blood flow. Trigeminal neuropathy, reported in association with PSS (Ashworth and Tait, 1971) , may be another example of vascular hyperreactivity.
Morphological changes are found in the small blood vessels. Maricq and LeRoy (1973) described the large dilated capillary loops in the nail beds of PSS patients, and Norton et al. (1968) showed on biopsy by electron microscopy of muscle tissue a reduction in the number of capillaries to only about 20% of the normal. Those remaining appeared abnormal. There was an increased number of venules. Similar but less severe changes were seen in systemic lupus erythematosus.
Narrowing and obstruction of the arterioles and small arteries have been demonstrated by arteriography by Dabich et al. (1972) . However, they could find only a poor correlation between the extent of the skin disease and the severity of the arterial disease. Sometimes obstruction of vessels antedated the skin disease and vice versa. Histological vascular abnormalities can be demonstrated in absence of sclerosis (Norton and Nardo, 1970) although the systemic nature of the disease usually reflects the systemic distribution of these lesions. The fact that normal skin in a PSS patient becomes scierodermatous when transplanted into an affected site makes it more likely that local vascular factors play some part in the pathogenesis of the disease (Fries et al., 1971) .
Characteristic histological changes are seen in the small arteries and arterioles in the kidneys, lungs, and other organs (D'Angelo et al., 1969; Trell and Lindstr6m, 1971; Cannon et al., 1974) . The vessels show concentric mucoid intimal proliferation which may obstruct their lumen. There may also be fibrosis of the adventitia. In the kidney there may be fibrinoid necrosis of the arterioles and glomerular changes which mimic the appearances in malignant hypertension. In the lungs the arterial lesions are typical of those of primary pulmonary hypertension. This is interesting because it is known that primary pulmonary hypertension may be associated with Raynaud's phenomenon.
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There is no evidence of sympathetic hyperactivity in the pathogenesis of the Raynaud's phenomenon (Fries, 1969; Sapira et al., 1972) . Although peritoneal fibrosis has been reported in the carcinoid syndrome (Hallen, 1964) there is no evidence to suggest that this is relevant to PSS (Tuffanelli, 1963) .
In the early stages of PSS inflammatory changes may be seen in the tissues (Rodnan and Medsger, 1966; Fleischmajer and Nedwich, 1972) , particularly as cuffs of chronic inflammatory cells around the small arteries and arterioles (Campbell and LeRoy, 1975) . They may be the result of the immune complex deposition described earlier. Johnson and Ziff (1974) suggested that lymphokine can stimulate the synthesis of collagen and so might lead to thickening of the vessel wall. Newly formed soluble collagen could diffuse through this wall into the lumen. One of the properties of collagen is that it binds platelets and could act as an initiating factor in intimal damage and vascular thrombosis (Spaet and Ts'ao, 1969; Puett et al., 1973; Jamieson, 1974) . This may be relevant to PSS. Once vascular narrowing is established hypoxia could stimulate further collagen synthesis (Chvapil et al., 1973) and so may perpetuate the disease.
Conclusion
There is now good evidence that excess collagen formation is an integral feature of PSS. Immunological changes certainly occur in association with this disease and may well be important in its pathogenesis. They may be responsible for vascular narrowing and obstruction, which in turn leads to collagen proliferation and atrophy of tissues. 
